Improving the Treatment of Brain Metastases in HER2-Positive Breast Cancers: Eternal Dream or Reality? Results of the NRG Oncology –KROG/RTOG 1119 Phase 2 Randomized Trial and Future Directions
The results of the NRG Oncology –KROG/RTOG 1119 phase 2 randomized trial are of great interest and are opening the door of the eternal question of whether we can improve the response of radiation therapy using its association with adapted targeted treatments in the treatment of brain metastases (BM) of breast cancer.1
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Youlia M. Kirova, Pierre Loap Tags: Editorial Source Type: research
More News: Biology | Brain | Brain Cancers | Breast Cancer | Cancer | Cancer & Oncology | HER2 | Neurology | Physics | Radiation Therapy | Radiology